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Abstract
Purpose: To assess the number of Streptococcus mutans in saliva of patients with denture 
stomatitis before and after antifungal therapy. 
Methods: After examining 93 patients, 47 were selected for fungal test. Then, from this sample, 
thirty patients were selected: 15 with positive and 15 with negative diagnosis for candidiasis 
that were evaluated for S. mutans counting, salivary flow and buffer capacity evaluation. Oral 
hygiene and prosthesis hygiene, period using prosthesis, lesion type and salivary data were 
related with clinical laboratorial characteristics of the patients with Candida. 
Results: The most frequent lesions were type I (43.5%) and II (53.5%). The amount of S. mutans 
was six times higher in patients with candidiasis and it was associated with low salivary flow and 
poor oral hygiene. After therapy, a reduction of S. mutans was verified particularly in patients 
with normal salivary flow. The values ranged from 0.01 to 3.88 x 104 cfu/mL. 
Conclusion: The data suggest that Streptococcus spp collaborates with Candida spp in the 
etiology and pathogenesis of denture stomatitis. The use of oral antimicrobial agents may 
provide a beneficial effect for denture stomatitis patients that are under antifungal therapy and 
that have poor oral hygiene and unfavorable salivary parameters.
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Resumo
Objetivo: Verificar o número de Streptococcus mutans em saliva de pacientes com estomatite 
protética antes e após a terapia antifúngica.
Metodologia: Após exame clínico de 93 pacientes, 47 foram selecionados para exame 
micológico e desta amostra foram selecionados trinta pacientes: 15 com diagnóstico positivo 
e 15 com diagnóstico negativo de candidose foram avaliados para contagem de S. mutans, 
determinação de fluxo salivar e capacidade tampão. Higiene bucal e da prótese, tempo de 
confecção, tipo de lesão e dados salivares foram relacionados com características clínicas e 
laboratoriais de Candida.
Resultados: As lesões frequentes foram dos tipos I (43,5%) e II (53,5%). A quantidade de S. 
mutans foi seis vezes maior em pacientes com candidose e foi associada com baixo fluxo salivar 
e higiene oral deficiente. Após a terapia, a redução de S. mutans foi verificada particularmente 
em pacientes com fluxo salivar normal. Os valores variaram de 0,01 a 3,88 UFC/ml x 104. 
Conclusão: Os dados sugerem que os Streptococcus colaboram com Candida spp na 
etiopatogenia da estomatite protética. O uso de agentes antimicrobianos orais pode propiciar 
efeito benéfico para pacientes com estomatite protética submetidos à terapia antifúngica e 
que apresentam higiene oral deficiente e parâmetros salivares desfavoráveis.
Palavras-chave: Prótese dentária; agentes antifúngicos; Candida; Streptococcus mutans
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Introduction
The  surface  of  acrylic  dentures  usually  host  several 
microorganisms (fungi and bacteria) that are difficult to 
remove even by vigorous mechanical cleaning or chemical 
agents (1). This environment produced by the prosthesis can 
promote yeast proliferation with or without predisposing 
local factors (2).
Denture stomatitis is an oral pathology of multifactorial 
etiology  that  affects  a  large  number  of  patients  using 
complete or partial dentures. The main etiologic factors 
related to denture stomatitis are trauma, poor oral hygiene 
and infection with Candida species. In general, the patients 
with denture stomatitis complain of edema, hyperemia, pain 
in the affected areas and burning mouth when a low salivary 
flow is taking place (3,4).
The adhesion of Candida cells to oral surfaces is a key initial 
event in pathogenesis of oral candidiasis, and the complex 
structure of oral flora with mixed species communities can 
intermediate the predisposition for many oral conditions 
including candidiasis (3). There are evidences that denture 
stomatitis is not a result of C. albicans solely, but rather it 
is an outcome of multispecies biofilms that may include 
Streptococcus mutans and Staphylococcus aureus (5,6). In 
fact, it has been already observed that co-adhesion between 
C. albicans and many Streptococcal spp. promotes oral 
colonization by yeast cells (6). Streptococcus mutans is a 
frequent member of acrylic dentures surfaces and if incubated 
simultaneously with Candida albicans may compete for 
biding sites but it can also promote yeast adhesion (5). This 
bacteria-yeast interaction has been a matter of investigation 
of many in vitro and in vivo studies (5,7-10). The analysis 
of the in vitro adherence of S. mutans and C.albicans can 
contribute to the understanding of the behavior of these 
organisms in the dental plaque. The interaction of these 
microorganisms in a combined culture can be understood as 
mutualistic, once both seem to be favored (11).
The adhesion is regarded as the first step for oral biofilm 
formation  and  distinct  mechanisms  of  adherence  can 
contribute for candidiasis resistance to antifungal therapeutic 
agents (8). In complex biofilms such as those found in the 
oral cavity, the ability of yeast to agglutinate with bacteria 
can be mediated by species interaction within the biofilm 
as well as by external factors like saliva, oral hygiene and 
exposure to antimicrobial agents (8,9). Despite the in vitro 
evidences of the Candida-bacteria interaction, few studies 
have investigated the S. mutans in patients with candidiasis 
or yeast related diseases (10,12). The aim of this study was 
to assess the number of Streptococcus mutans in saliva of 
patients with diagnosis of denture stomatitis before and after 
antifungal therapy. 
Methods
The study protocol was approved by the Local Ethical 
Committee  of  the  Federal  University  of  Paraíba,  João 
Pessoa, PB, Brazil. Only patients who were assisted at 
the dental clinic and signed the consent were selected for 
the research. The criterion for participating in the research 
was dental prosthesis users. The exclusion criteria were: 
patients with systemic predisposing or confounding factor 
(diabetes, hyperthyroidism, immune diseases, radiotherapy 
and  chemotherapy  treatments),  use  of  medicines  that 
could affect any Candida infection such as antidepressive, 
immunosuppressive and anti-bacterial agents (2).
A  total  of  93  patients  were  examined  and  forty  seven 
presented clinical signs of denture stomatitis. The clinical 
signs were classified in three stages described by Newton 
as pin-point hyperemia, diffuse hyperemia and nodular 
hyperemia of the entire denture area (13).
Swabs were used for collecting material from prosthesis 
(P1) and palatine lesions (P2) of patients with candidiasis. 
The material was subsequently placed on CHROMagar 
Candida for culture, isolation and identification of fungi 
species. CHROMagar is a selective and differential medium 
that allows selective isolation of yeasts and simultaneously.
identifies  (by  color  reactions  and  colony  morphology) 
colonies of C. albicans ,C. tropicalis and C. Krusei with a 
high degree of accuracy (14).
Mycological exams as described previously were carried out 
in this sub-sample (4). The presence of Candida infection 
was confirmed in 32 patients, but only 15 presented more than 
20 cfu (Colony Forming Units), a level which characterizes 
infection (1). Finally, the sample was composed of 30 
patients with denture stomatitis: 15 with candidiasis and 15 
without candidiasis. 
Antifungal therapy was applied for the 15 patients who 
were positive for candidiasis. The patients received a tube 
of a commercial antifungal medicine (Daktarin® gel oral, 
Janssen Cilag Farmacêutica, 40 g) and instruction for using 
3 times a day for two weeks. They were instructed to use a 
sufficient amount of gel that could cover the affected areas 
as recommended by the manufacturer. Denture were cleaned 
each night with neutral soap and washed with tap water. 
Patients were strongly requested to avoid using dentures at 
night during the test period.
Before starting the therapeutic period, oral hygiene parameters 
and salivary test were carried out before the therapeutic period 
of 2 weeks. Mycological and microbiological tests were 
carried out twice: before the patients have started using the   
medicine and two days after finishing the therapeutic period. 
Oral  hygiene  and  prosthesis  hygiene  parameters  were 
collected according to the guidelines of Sakki et al. (15). 
Saliva parameters (stimulated salivary flow rate and buffer 
capacity) were collected as described by Krasse et al. (16). 
The patients were classified in three levels of salivary flow 
rate: a) hiposalivation = 0.7mL/min, b) intermediate salivary 
flow = 0.71 up to 1.0 mL/min and c) normal salivary flow 
when above 1.1 mL/min. For buffer capacity, the reference 
levels were considered as normal for pH above 5 and low 
for pH below or equal to 4. The pH measurements were 
determined using indicate paper but intermediate values 
were checked in pH electrode for final classification (below 
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The S. mutans counting was carried out for all 30 patients 
at baseline and for 15 patients after using the antifungal 
medicine.  Non-stimulated  saliva  samples  were  placed 
in Brain Heart Infusion (BHI, Difco) and later on MSB 
medium: mitis salivarius agar (Difco) supplemented with 440 
mM sucrose, 39 mM potassium tellurite and 0.2 units/mL 
of bacitracin, as recommended by Gold et al. (17). All 
procedures were in duplicate. 
Statistical analysis was carried out using SPSS (Statistical 
Package for Social Sciences) v.10.0. The assumptions of 
equality of variances and normal distribution of errors were 
checked for all numerical variables. Since the distribution of 
the errors was homogeneous, data were tested by Student’s 
T test with a significance level of 5%.
Results
Most patients were female (n=24) with an age range between 
27 and 69 years-old. Within this range, the most frequent 
observations  were  between  49  up  to  59-years-old. The 
lesions types observed were type I (43.5%) and type II 
(53.5%). Type III composed 3% of the lesions.
Candida  albicans  was  the  predominant  yeast  isolated 
(86.6%) followed by. C. tropicalis, C. parapisilosis, C. 
glabrata e C. krusei.
Table 1 shows the mean fcu/mL of S. mutans and Candida 
spp of all patients. Ten subjects who showed high counts 
of Candida in the prosthesis were positive for candidiasis 
and were also with high number of S. mutans in saliva. 
N
N of colonies of Candida spp
Candidiasis S. mutans
Percentile (50%)
S. mutans
(n x 104 cfu/mL) Prosthesis Palate
1 0 0 - - 1
2 0 0 - - 3
3 0 0 - - 11
4 0 0 - - 12
5 0 0 - - 13
6 > 200 17 + - 14
7 0 0 - - 16
8 0 0 - - 16
9 103 > 200 + - 17
10 >200 0 + - 17
11 0 0 - - 23
12 0 0 - - 24
13 >200 122 + - 26
14 0 0 - - 29
15 0 0 - - 29
16 > 200 113 + - 29
17 0 0 - + 53
18 0 0 - + 55
19 0 0 - + 58
20 0 0 - + 85
21 > 200 20 + + 92
22 > 200 126 + + 154
23 > 200 0 + + 174
24 116 19 + + 175
25 > 200 149 + + 206
26 > 200 0 + + 254
27 > 200 93 + + 322
28 183 0 + + 382
29 170 0 + + 446
30 > 200 39 + + 495
Table 1. Mean cfu/mL of S. mutans and Candida spp of 30 patients (15 patients positive and 15 negative 
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Table 2 shows the reduction in salivary S. mutans (cfu/mL) 
after the antifungal therapy. In percentages, the differences 
range from 3.8 up to 82% with a mean reduction of 45%.
Table 3 presents the mean (SD) values (cfu/mL) of S. mutans 
of patients before the antifungal therapy (baseline) according 
to other parameters. Table 4 presents the distribution of 
patients categorized in low and high S. mutans counting 
(cfu/mL) of patients who with and without candidiasis. The 
estimate amount S.mutans of in saliva among patients with 
deficient hygiene was ten fold higher compared to those with 
good hygiene. Among those patients with deficient hygiene 
(n=13), the mean (SD) values (cfu/mL) of S.mutans were 
2.24(1.50) and 0.93(0.50) before and after the antifungal 
therapy, respectively. For those with good hygiene (n=2) 
there values were 0.21(0.10) and 0.12(0.01), respectively.
Table 2. Mean, standard deviation 
and confidence interval of   
S. mutans (cfu/mL) in saliva of 
patients (n=15) before and after   
the use of antifungal medicine.
N
Antifungal therapy
Difference
(n x 104 cfu/mL) Before (baseline)
 (n x 104 cfu/mL) 
After
(n x 104 cfu/mL)
Mean 1.97 0.83 1.14
Standard deviation 1.56 0.57 1.27
Confidence interval 1.10-2.83 0.51-1.14 0.43-1.84
Table 3. Mean (SD) of fcu/mL of S. mutans (baseline), time of use of prosthesis, salivary flow rate, buffer capacity of patients who 
with and without candidiasis. 
Candidiasis N S. mutans
(n x 104 cfu/mL)
Period of using prosthesis
(months)
Salivary flow rate 
(mL/min)
Buffer capacity 
(pH)
Negative 15 0.3   (0.22)a 69.1 (49.3)a 1.2 (0.3)a 6.6 (0.7)a
Positive 15 1.97 (1.56)b 95.6 (83.5)b 0.7 (0.2)b 5.2 (1.2)b
Means in the same column followed by distinct superscripts indicate statistical significance (Student T test, P<0.05). 
S. mutans 
(n x 104 fcu/mL)**
Diagnosis of candidiasis
Total
Negative Positive
Low 11 5 16
High 4 10 14
Total 15 15 30
* Chi-square = 4.82, d.f.=1, p<0.05.
** cut-off point of  29  x 104 cfu/mL of S. mutans (percentile 50%). 
Table 4. Relationship between 
patients who showed low or high 
S. mutans in saliva and patients 
diagnosed as Candida-positive 
(presence of C. albicans on 
prosthesis or palate).* 
Discussion
C. albicans was the major isolated yeast in the selected 
subjects. This was also observed in other studies (2,9). The 
predominant site for colonies was the prosthesis indicating 
the importance of the mechanism of adherence of yeast cells 
on a non-shedding surface (6,15). Adhesion is the first step 
for yeast colonization on the oral epithelium, and dentures 
may  become  an  important  source  for  reinfection  (18).   
For denture stomatitis patients the risk of candidiasis is   
high since porous acrylic surfaces can provide more biding 
sites  than  natural  teeth  and  shedding  surfaces  as  oral   
mucosa (1).
Shinada et al. (8) observed that the presence of Candida was 
highest on the mucosal denture surfaces followed by clasp, 
tongue, and remaining teeth. Therefore, it is not a surprise 
that a significant number of patients could harbor Candida 
albicans in the prosthesis as shown in Table 1. From the 
clinical point of view an endogenously re-colonization of 
Candida in some patients cannot be disregarded. Candida 
is  usually  ubiquitous  in  the  oral  mouth  and  digestive 
tract. Thus a re-infection can be originated from external 
and internal sources, or both. Age of the prosthesis, oral 
hygiene and ability to penetrate the oral mucosa are certainly 
important variables to be considered for those less successful 
cases (1,2). How far oral hygiene and the counting of   124  Rev. odonto ciênc. 2010;25(21):120-125
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S. mutans can influence re-infection, this is still a matter of   
debate (7).
Recently, many investigations have focus more on biofilm 
formation than in planktonic cells to explain the bacterial 
behavior in the in vivo oral environment (19). Regarding 
candidiasis, few studies have investigated the bacteria-yeast 
relationship using clinical parameters that can modulate 
the biofilm formation on different surfaces (5,10,12). It 
is  important  to  consider  bacterial-Candida  interactions 
in  the  study  of  fungal  virulence. Aspects  of  the  host’s 
microbial  community  might  normally  protect  against 
fungal proliferation or might play an important role in the 
preparation of the fungus for its role in the infection. Also, 
mixed bacterial-fungal infections might have properties that 
are distinct from single-species infections (20). These co-
species communities, probably existing as a mixed biofilm, 
are difficult to treat with antibiotics and antifungals (6).
Saliva and oral hygiene can be important mediators for oral 
biofilm development. Specific salivary components may act 
promoting yeast-bacteria co-aggregation and adherence to 
oral surfaces (9,4,17). Low salivary flow can also facilitate 
biofilm development and this is certainly a matter of concern 
when treating old subjects prone to dry mouth related 
problems (8,17).
In our study, Candida spp cfu values were obtained from 
biofilm material of dentures or palatal lesions, whereas. S. 
mutans cfu levels were evaluated from saliva samples as an 
indication of S. mutans counting. Although S. mutans are 
major constituents of cariogenic oral biofilms, the saliva 
counting can be a good indicator of the major oral biofilms 
in the mouth in many oral conditions (21,22). In fact, a 
variation of S. mutans cells in different sites of the mouth is 
expected. Therefore, the option of collecting the S.mutans 
data from saliva was regarded as appropriate. In addition, all 
procedures were carried out following established guidelines 
of material collection (16). In any case, considering the cfu 
counting of S.mutans in the evaluated subjects, one must 
estimate that in denture oral biofilms there are at least 5-fold 
more bacteria than those found in saliva. Girad Junior et al. 
(2) observed that the dental biofilm formed in the presence 
of sucrose would be an indirect contributing factor for yeast 
adherence due to an increase in Streptococcus spp. As shown 
in Tables 1 and 4, most of the subjects with high counts 
of Candida also had high counts of S. mutans. Moreover, 
subjects with candidiasis and high amounts of S.mutans in 
the oral mouth were the virtually the same with unfavorable 
salivary parameters and poor oral hygiene. The question 
at this point is not if a potentialization of the adherence 
capacity of Streptococcus mutans and Candida albicans 
takes place in a biofilm development, but rather if this 
synergic effect can be estimated or predicted clinically. The 
clinical implications of these results are that candidiasis 
treatment can be more effective when including frequent oral 
hygiene measures to reduce biofilm formation and S.mutans 
in the oral mouth (23). On the other hand, a risk for dental 
caries due to Candida is likely as reported by Moalic et al. 
(24) and Nikawa et al. (25). A low biofilm pH may favor S. 
mutans but Candida can also take advantage of adherence 
mechanism in such environment. 
The observation of lesions types I and II in these subjects 
indicates that candidiasis was not an acute event in these 
patients.  Poor  oral  hygiene  and  unfavorable  salivary 
parameters can probably aggravate this condition by many 
ways including the Candida-Streptococcus co-aggregation. 
From the clinical point of view, compliance for oral health 
instructions can be problematic. Therefore, in addition to 
oral hygiene instructions, the use of antimicrobials might 
be an interesting choice to patients with a high S. mutans 
counting and resistant candidiasis. 
Conclusions
It can be concluded that: 
1. S. mutans counting was higher in patients with candidiasis 
and it was associated with low salivary flow and poor oral 
hygiene; 
2. After therapy, it was verified a reduction of S. mutans 
particular  in  patients  with  normal  salivary  parameters; 
and
3. Streptococcus spp collaborates with Candida spp in the 
etiology and pathogenesis of denture stomatitis. The use of 
oral antimicrobial agents may provide a beneficial effect for 
denture stomatitis patients that are under antifungal therapy 
and that have poor oral hygiene and unfavorable salivary 
parameters.
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